Mammalian agmatinase inhibitory substance

Details Mammalian agmatinase inhibitory substance Mammalian agmatinase inhibitory substance

2008-03-25

2008-03-25

Jones, Dameron L. (Department: 1618)

Drug, bio-affecting and body treating compositions

In vivo diagnosis or in vivo testing

C424S001110, C424S001650, C514S157000, C514S183000

Reexamination Certificate

active

10818249

ABSTRACT:
The present invention provides for methods and compounds for treating brain trauma and disorders such as: ischemia, stroke, neurodegenerative disorders, opioid addiction, idiopathic pain, epilepsy, and depression. More specifically, the invention provides methods for designing and identifying inhibitors of mammalian agmatinase and for compounds identified by these methods.

REFERENCES:
Dox et al, The Harper Collins Illustrated Medical Dictionary, 1993, pp. 125, 126, 133, 152, 227, 308, 348, 355, 356, and 454.

Affiliated with

Also associated with

Rating

Mammalian agmatinase inhibitory substance does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Mammalian agmatinase inhibitory substance, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Mammalian agmatinase inhibitory substance will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3948132